These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35433476)

  • 41. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
    Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
    Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma.
    Guo J; Yang Q; Wei S; Shao J; Zhao T; Guo L; Liu J; Chen J; Wang G
    BMC Cancer; 2022 Jul; 22(1):745. PubMed ID: 35799142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long noncoding RNA VPS9D1-AS1 promotes esophageal squamous cell carcinoma progression via the Wnt/β-catenin signaling pathway.
    Ma L; Yan W; Sun X; Chen P
    J Cancer; 2021; 12(22):6894-6904. PubMed ID: 34659577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Downregulation of H19 decreases the radioresistance in esophageal squamous cell carcinoma cells.
    Luo W; Liu W; Yao J; Zhu W; Zhang H; Sheng Q; Wang L; Lv L; Qian L
    Onco Targets Ther; 2019; 12():4779-4788. PubMed ID: 31417277
    [No Abstract]   [Full Text] [Related]  

  • 45. Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
    Tang X; Fan Z; Wang Y; Ji G; Wang M; Lin J; Huang S
    Dis Esophagus; 2016 Apr; 29(3):207-14. PubMed ID: 25287007
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retracted Article: Panax notoginseng saponins regulate VEGF to suppress esophageal squamous cell carcinoma progression
    Chen X; Lv Z; Zhang C; Wang X; Zhao Y; Wang X; Zheng Y
    RSC Adv; 2020 Jan; 10(6):3256-3265. PubMed ID: 35497711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Knockdown of long non-coding RNA CCAT2 suppresses growth and metastasis of esophageal squamous cell carcinoma by inhibiting the
    Yang C; Li F; Zhou W; Huang J
    J Int Med Res; 2021 May; 49(5):3000605211019938. PubMed ID: 34057837
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Capn4 promotes esophageal squamous cell carcinoma metastasis by regulating ZEB1 through the Wnt/β-catenin signaling pathway.
    Zhao YL; Li JB; Li YJ; Li SJ; Zhou SH; Xia H
    Thorac Cancer; 2019 Jan; 10(1):24-32. PubMed ID: 30444080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpression of β-Catenin Decreases the Radiosensitivity of Human Nasopharyngeal Carcinoma CNE-2 Cells.
    He H; Lin K; Su Y; Lin S; Zou C; Pan J; Zhou Y; Chen C
    Cell Physiol Biochem; 2018; 50(5):1929-1944. PubMed ID: 30396174
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Demethylzelasteral inhibits proliferation and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma.
    Yu J; Wang W; Liu B; Gu J; Chen S; Cui Y; Sun G
    J Cancer; 2021; 12(13):3967-3975. PubMed ID: 34093803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis.
    Feng L; Zhao K; Sun L; Yin X; Zhang J; Liu C; Li B
    J Transl Med; 2021 Aug; 19(1):367. PubMed ID: 34446045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of PRR11 promotes tumorigenic capability and is associated with progression in esophageal squamous cell carcinoma.
    Zhou L; Deng ZZ; Li HY; Jiang N; Wei ZS; Hong MF; Wang JH; Zhang MX; Shi YH; Lu ZQ; Huang XM
    Onco Targets Ther; 2019; 12():2677-2693. PubMed ID: 31040705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating beta-catenin/TCF pathway.
    Wang Y; Zhou X; Zhu H; Liu S; Zhou C; Zhang G; Xue L; Lu N; Quan L; Bai J; Zhan Q; Xu N
    Oncogene; 2005 Oct; 24(44):6637-45. PubMed ID: 16007168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Up-regulation of microRNA-136 induces apoptosis and radiosensitivity of esophageal squamous cell carcinoma cells by inhibiting the expression of MUC1.
    Huang HZ; Yin YF; Wan WJ; Xia D; Wang R; Shen XM
    Exp Mol Pathol; 2019 Oct; 110():104278. PubMed ID: 31247211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibiting UHRF1 expression enhances radiosensitivity in human esophageal squamous cell carcinoma.
    Yang C; Wang Y; Zhang F; Sun G; Li C; Jing S; Liu Q; Cheng Y
    Mol Biol Rep; 2013 Sep; 40(9):5225-35. PubMed ID: 23943380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Downregulated MEG3 contributes to tumour progression and poor prognosis in oesophagal squamous cell carcinoma by interacting with miR-4261, downregulating DKK2 and activating the Wnt/β-catenin signalling.
    Ma J; Li TF; Han XW; Yuan HF
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1513-1523. PubMed ID: 30990378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of nuclear β-catenin in rectal adenocarcinoma is associated with radioresistance.
    Wang L; Zhang XM; Li Z; Liu XJ; Chai J; Zhang GY; Cheng YF
    World J Gastroenterol; 2013 Oct; 19(40):6876-82. PubMed ID: 24187464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long non-coding RNA DUXAP8 regulates proliferation and invasion of esophageal squamous cell cancer.
    Xu LJ; Yu XJ; Wei B; Hui HX; Sun Y; Dai J; Chen XF
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2646-2652. PubMed ID: 29771416
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long noncoding RNA FEZF1-AS1 promotes the motility of esophageal squamous cell carcinoma through Wnt/β-catenin pathway.
    Yang L; Ye Y; Chu J; Jia J; Qu Y; Sun T; Yin H; Ming L; Wan J; He F
    Cancer Manag Res; 2019; 11():4425-4435. PubMed ID: 31191005
    [No Abstract]   [Full Text] [Related]  

  • 60. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway.
    Ge C; Wu S; Wang W; Liu Z; Zhang J; Wang Z; Li R; Zhang Z; Li Z; Dong S; Wang Y; Xue Y; Yang J; Tan Q; Wang Z; Song X
    Oncotarget; 2015 May; 6(13):10964-77. PubMed ID: 25844602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.